Optivia Biotechnology, Inc.

Part of Bioivt, LLC

UEI
NAEEL8RLVEJ8
CAGE
4YJF2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

FY2025 rankings

Its parent company, Bioivt, LLC, ranks #45 in NAICS 325414

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
  • Bioivt, LLC Parent Woodbury, NY L2BGKGC6LJW7
    • Optivia Biotechnology, Inc.
SAM.gov registration date
Website
bioivt.com
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
A novel mechanistic modeling platform for predicting drug clearance and disposition mediated by transporters and enzymes R43GM113597 National Institute of General Medical Sciences (NIH) $225,000
Establishing a comprehensive inhibitory profile of marketed drugs against CNS TRA R43FD004297 Food and Drug Administration $150,000
A comprehensive platform to study drug interaction with physiologically important R44MH103850 National Institutes of Health $1,802,094
A transporter-based predictive adme platform R43RR031474 National Institutes of Health $439,346
Development of a comprehensive cell-based transporter assay platform R43GM086970 National Institutes of Health $406,969

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Optivia Biotechnology, Inc. registered in SAM.gov?

Optivia Biotechnology, Inc.'s SAM.gov registration expired on October 17, 2020.

How does Optivia Biotechnology, Inc. rank among federal contractors?

Optivia Biotechnology, Inc.'s parent company, Bioivt, LLC, ranked #45 in NAICS 325414 in FY2025.

What is Optivia Biotechnology, Inc.'s most recent federal award?

Optivia Biotechnology, Inc.'s most recent federal grant award is A novel mechanistic modeling platform for predicting drug clearance and disposition mediated by transporters and enzymes (R43GM113597), from National Institute of General Medical Sciences (NIH), on January 15, 2015.

On GovTribe

See Optivia Biotechnology, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login